Matches in Wikidata for { <http://www.wikidata.org/entity/Q58434925> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q58434925 description "article scientifique publié en 2008" @default.
- Q58434925 description "artículu científicu" @default.
- Q58434925 description "im Oktober 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58434925 description "wetenschappelijk artikel" @default.
- Q58434925 description "наукова стаття, опублікована в жовтні 2008" @default.
- Q58434925 name "Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy" @default.
- Q58434925 name "Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy" @default.
- Q58434925 type Item @default.
- Q58434925 label "Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy" @default.
- Q58434925 label "Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy" @default.
- Q58434925 prefLabel "Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy" @default.
- Q58434925 prefLabel "Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy" @default.
- Q58434925 P1433 Q58434925-EF0AB175-2C21-4700-8E6B-A853810654F3 @default.
- Q58434925 P1476 Q58434925-979B272D-B45B-45CB-AA15-2B139FDFFCF7 @default.
- Q58434925 P2093 Q58434925-498195DD-D230-4B40-A9D9-8DE041BF6F3E @default.
- Q58434925 P2093 Q58434925-4F7C1C13-382B-4011-A718-65AB6820E04F @default.
- Q58434925 P2093 Q58434925-748834B2-99AE-4CE6-93F7-ECCB7F110398 @default.
- Q58434925 P2093 Q58434925-74BC30AE-1671-46E7-BC48-C02D67F3F938 @default.
- Q58434925 P304 Q58434925-5C571A47-AF6A-49E5-A51F-34FCD5279AC1 @default.
- Q58434925 P31 Q58434925-CF35B61A-E3D3-4DE0-9F6C-95C6DF0EC6A4 @default.
- Q58434925 P356 Q58434925-EA9F746D-0B64-49B6-9AFC-6362BFCDD9E3 @default.
- Q58434925 P433 Q58434925-5D785047-9A76-4FDE-9E4B-A00C3FEA4296 @default.
- Q58434925 P478 Q58434925-8633A3BA-2E70-4887-B021-491CF625D2E1 @default.
- Q58434925 P50 Q58434925-44DF6042-1618-44B7-9DB9-C76C6AC8CEB6 @default.
- Q58434925 P50 Q58434925-6409844D-EA3C-4B90-8439-148660164462 @default.
- Q58434925 P50 Q58434925-989DCF56-2CEE-4486-B336-5B43EB1FA9ED @default.
- Q58434925 P577 Q58434925-B739A2BB-4E6A-41EA-BA7C-F340D5DA7F5B @default.
- Q58434925 P698 Q58434925-DD00F4B8-26DF-49F9-BB9D-F9B4DFE84502 @default.
- Q58434925 P921 Q58434925-37511EA8-0BF6-4E88-85DB-D3220D897CF2 @default.
- Q58434925 P356 000168086 @default.
- Q58434925 P698 18971577 @default.
- Q58434925 P1433 Q5262700 @default.
- Q58434925 P1476 "Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy" @default.
- Q58434925 P2093 "Elisabetta Botti" @default.
- Q58434925 P2093 "Giulia Spallone" @default.
- Q58434925 P2093 "Marina Papoutsaki" @default.
- Q58434925 P2093 "Sergio Chimenti" @default.
- Q58434925 P304 "146-150" @default.
- Q58434925 P31 Q13442814 @default.
- Q58434925 P356 "10.1159/000168086" @default.
- Q58434925 P433 "2" @default.
- Q58434925 P478 "218" @default.
- Q58434925 P50 Q38319077 @default.
- Q58434925 P50 Q42770497 @default.
- Q58434925 P50 Q57035420 @default.
- Q58434925 P577 "2008-10-30T00:00:00Z" @default.
- Q58434925 P698 "18971577" @default.
- Q58434925 P921 Q367700 @default.